Back to today’s briefing

Story perspectives

Medline Targets $7 Billion IPO Amid Strong Sales Surge

12/17/2025

43 5 Full Breakdown

Summary

Story summary

Medline, a Northfield-based medical supplies company, plans an IPO up to $7 billion, issuing 179 million shares at $26–$30.
Medline reported net sales of $20.6 billion for nine months ending September 2025, up from $18.7 billion the prior year.
The IPO is expected to price late Tuesday, led by Goldman Sachs, Morgan Stanley, Bank of America, and JPMorgan.
Medline employs over 43,000 people globally.

1 of 1

Story summary

Medline, a Northfield-based medical supplies company, plans an IPO up to $7 billion, issuing 179 million shares at $26–$30.
Medline reported net sales of $20.6 billion for nine months ending September 2025, up from $18.7 billion the prior year.
The IPO is expected to price late Tuesday, led by Goldman Sachs, Morgan Stanley, Bank of America, and JPMorgan.
Medline employs over 43,000 people globally.